| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 3,125.4 | 3,560.4 | 4,470.3 | 4,699.1 | 4,595.4 |
| Age-adjusted comparative prevalence of diabetes, % | - | 5.1 | 6.4 | 7.4 | 8.0 |
| People with undiagnosed diabetes, in 1,000s | - | - | 1,497.7 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 33.5 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 4,342.6 | 4,907.3 | 4,964.4 | 4,733.2 |
| Age-adjusted comparative prevalence of IGT, % | - | 7.3 | 8.4 | 9.0 | 9.4 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 1,625.3 | 1,630.3 | 1,462.4 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 2.8 | 3.1 | 3.2 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 26,111.0 | 172,943.0 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | 1.8 | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 0.8 | 0.1 | 1.3 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 1.7 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 5.1 | - | 7.9 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 13.7 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | 80,377.1 | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 14.3 | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 2,491.4 | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 2,763.6 | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | - | 14,666.2 | 14,557.2 | 13,142.5 |
| Total diabetes-related health expenditure, ID million | - | - | 17,782.4 | 17,650.2 | 15,934.9 |
| Diabetes-related health expenditure per person, USD | - | 3,541.0 | 3,280.8 | 3,256.4 | 2,939.9 |
| Diabetes-related health expenditure per person, ID | - | - | 3,977.9 | 3,948.3 | 3,564.6 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 43,910.0 | 45,637.1 | 45,153.7 | 44,411.8 | 40,178.6 |
| Population of children (0-14 y), in 1,000s | 9,161.0 | - | 7,718.5 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 10,610.0 | - | - |
| Complications of diabetes | |||||
| Microvascular |
| ||||
| Macrovascular |
| ||||